| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |